Diaceutics Plc (DXRX) Ord GBP0.002
Share news, reports & tips
11 January 2021 16:12
(Sharecast News) - Diaceutics updated the market on its trading in 2020 on Monday, reporting that its revenue and adjusted EBITDA for the year ended 31 December were expected to be around £12.6m, down from...
28 October 2020 13:48
(Sharecast News) - Diaceutics announced the launch of its 'DXRX - The Diagnostic Network digital platform on Wednesday, which it said was designed to accelerate the development and commercialisation of...
22 July 2020 09:45
(Sharecast News) - Diagnostic commercialisation company Diaceutics announced a new, "significant" client contract win with an unnamed pharmaceutical company on Wednesday.
8 July 2020 08:06
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Wednesday that it had built on its good start to the financial year, with trading in the first half in line with expectations.
11 June 2020 12:33
(Sharecast News) - Diagnostics commercialisation company Diaceutics has conditionally raised £20.5m before expenses, through a placing of 14,137,931 new shares at 145p each to existing and new investors in...
19 May 2020 10:56
(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with the board's expectations.
29 April 2020 09:29
(Sharecast News) - Precision diagnostics commercialisation company Diaceutics announced research results from its Covid-19 oncology tracker on Wednesday, which it said showed the impact of the crisis on...
13 January 2020 10:44
(Sharecast News) - Pharmaceutical data analytics and implementation services provider Diaceutics updated the market on its trading for the year ended 31 December on Monday, reporting that as a result of a...
8 July 2019 10:11
(Sharecast News) - Data analytics and implementation services firm Diaceutics said on Monday that it had continued to trade in line with market expectations throughout the six months ended 30 June.
21 March 2019 09:55
(Sharecast News) - Data analytics and implementation services company Diaceutics confirmed the admission of its entire issued ordinary share capital, which comprises 69,583,077 ordinary shares, to trading on...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.